Skip To Main Content
Site Name Here
MenuSearchA-ZSeven Schools One UniversitySeven Schools One University

Menu

  • Give
  • Apply
  • Visit
Close Menu
About
  • Administrative Offices
  • Campus Maps
  • Core Values
  • Fast Facts
  • Travel and International Services
  • Other USM Schools
  • Policies and Procedures
  • Strategic Plan
  • Sustainability
  • Middle States
  • MPowering the State
  • News
  • University Leadership
  • UMB Experts Guide
Academics
  • Academic Calendar
  • Academy of Lifelong Learning
  • Blackboard
  • Libraries
  • Office of the Provost
  • SURFS
  • UMB Program Explorer
Admissions
  • Financial Aid
  • International Students
  • Military and Veterans
  • Office of the Registrar
Research
  • Breakthroughs Can’t Wait
  • Offices and Contacts
  • Resources for Investigators
  • Services for Investigators
  • UMB Research Profile
University Life
  • Arts and Culture
  • Bookstore
  • Emergency
  • Housing
  • Museums
  • Parking and Transportation Services
  • Rooms Available on Campus
  • SMC Campus Center
  • Student Organizations
  • Student Policies
  • URecFit and Wellness
  • UMB shuttle
  • Welcome to Baltimore
  • One Card
Info For
  • Current Students
  • Faculty and Staff
  • Alumni and Donors
  • Community Members
Resources
  • The Elm
  • Calendar
  • myUMB
  • Directory
  • Blackboard
  • SURFS
  • Emergency
  • UMB Shuttle
Seven Schools One University

Search

Close Menu
Common Searched Terms
  • Graduation 2025
  • Campus Tour
  • Jobs at UMB
  • Parking
  • Tuition Remission
  • Registrar
  • Qualtrics
  • Human Resources
  • URecFit and Wellness
  • Tuition
  • Help Desk

A–Z

Close Menu
    Center for Global Engagement

    February 2024 Newsletter

    1. UMB Home
    2. About UMB
    3. Travel and International Services
    4. Center for Global Engagement
    5. Our Global Campus
    6. UMB Global Newsletter
    7. Archived CGE Global Newsletters
    8. 2024 CGE Global Newsletters
    9. February 2024 Newsletter
    • UMB HomeAbout UMBTravel and International ServicesCenter for Global EngagementOur Global CampusUMB Global NewsletterArchived CGE Global Newsletters2024 CGE Global NewslettersFebruary 2024 Newsletter

    Round Up of CVD's Typhoid Efforts: Typhoid Mary to Typhoid Conjugate Vaccines, How Far We've Come

    Typhoid Mary to typhoid conjugate vaccines – how far we have come

    In the early 1900s, cook Mary Mallon – also known as Typhoid Mary – infected 50 to over 100 people with typhoid. As she changed jobs, she took typhoid with her from household to household. While typhoid is a disease of the past in developed countries, it still plagues many in low- and middle-income countries. The Typhoid Vaccine Acceleration Consortium (TyVAC) – led by the Center for Vaccine Development and Global Health (CVD) – has joined forces to Take on Typhoid.

    A recently published Typhoid Fever Nature Reviews Primer and blog – co-authored by CVD’s Dr. Kathleen Neuzil and TyVAC partners – provides a comprehensive overview of the epidemiology, disease burden, risk factors, genomics, and challenges, including multidrug resistance, diagnostics, and clinical presentation, as well as recent advances in the vaccine pipeline, clinical trial data, and the potential for disease prevention and reduction.

    Typhoid, a serious and sometimes fatal bacterial infection is caused by Salmonella enterica serovar Typhi. Typhoid is spread through contaminated food and water, and feces. In 2019, more than 9 million cases and 110,000 deaths were attributed to typhoid. Luckily, there is a safe and cost-effective typhoid conjugate vaccine (TCV). Pakistan, Samoa, Liberia, Nepal, Zimbabwe – and recently Malawi – have successfully introduced TCVs into their national immunization programs. Taking on typhoid requires a coordinated that includes improved diagnostics and water, sanitation, and hygiene infrastructure. TCVs can help shape a future where typhoid is a disease of the past.


    Reaching Zero-Dose Children in Nepal

    A young child sits holding her upper arm, like she just received a shotIn April 2022, Nepal vaccinated more than 7 million children during a national campaign to introduce typhoid conjugate vaccine (TCV). The national campaign was also an opportunity to identify and reach zero-dose (ZD) children – those younger than 2 years old who have not received any routine vaccinations - or who are under-immunized. Trained healthcare workers used vaccination cards to track children with missed doses and offered guidance to caregivers, advising them to visit the nearest health facility to access missed vaccines. The outreach strategies and lessons learned through TCV introduction provide a roadmap for others working to reach ZD children and missed communities, ensuring that all children are protected from typhoid.

    The Typhoid Vaccine Acceleration Consortium (TyVAC), led by UMSOM’s Center for Vaccine Development and Global Health, works to decrease the burden of typhoid by accelerating the introduction of TCVs in high-risk countries.


    Typhoid conjugate vaccine provides sustained protection beyond 4 years

    A woman gives a shot to a child while others wait in lineResearchers at the Malawi-Liverpool-Wellcome Trust confirmed typhoid conjugate vaccines (TCVs) prevent blood culture-confirmed typhoid for over 4 years among children 9 months-12 years.

    In this study, children were randomly assigned to receive either a single dose of TCV or meningococcal capsular group A conjugate (MenA) vaccine. The research team conducted passive surveillance across four sites, where vaccinated participants were tested for typhoid fever and other pathogens if they presented with a fever. Over 7 months, a total of 24 children in the TCV group and 110 children in the MenA group had a positive blood culture for typhoid. The overall vaccine efficacy of TCV after more than 4 years was 78.3%, with an estimated 1.3% decline in efficacy per year.

    As emphasized in the accompanying commentary, a single dose of TCV is both safe and well-tolerated, demonstrating effectiveness in protecting against typhoid. These longer-term data are pivotal for decision-makers in prioritizing the introduction of TCVs.

    The Typhoid Vaccine Acceleration Consortium (TyVAC), led by UMSOM’s CVD, works to address the disease burden by accelerating the introduction of TCVs in high-risk countries.


    • Back to February 2024 Newsletter

    Contact

    Center for Global Engagement

    621 W. Lombard St.
    Suite 330
    Baltimore, MD 21201

    410-706-6331 globaltimore@umaryland.edu

    Related Information

    Global Hub Office of International Services
    University of Maryland Baltimore

    The University of Maryland, Baltimore is the founding campus of the University System of Maryland.

    620 W. Lexington St., Baltimore, MD
    21201 | 410-706-3100

    • The Elm
    • Calendar
    • Emergency
    • Mobile UMB
    • UMB Shuttle
    • myUMB
    • Directory
    • IT Help Desk
    • Facilities Work Request
    • Jobs
    • Middle States
    • Strategic Plan
    • Sustainability
    • Clery Report
    • UMB Hotline
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • YouTube
    The University of Maryland, Baltimore prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to the Title IX Coordinator. Read the UMB Notice of Non-Discrimination.
    © 2024-2025 University of Maryland, Baltimore. All rights reserved.
    • Privacy Policy
    • Web Accessibility
    • Web Feedback
    • Non-Discrimination